These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2284754)

  • 41. Vitamin status in patients on maintenance haemodialysis.
    Kelleher J; Mascie-Taylor BH; Davison AM; Bruce G; Losowsky MS
    Int J Vitam Nutr Res; 1983; 53(3):330-7. PubMed ID: 6629672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Seasonal variations of vitamin sufficiency in pregnant women (Mzensk City)].
    Vrzhesinskaia OA; Il'iasova NA; Isaeva VA; Taranova AG; Beketova NA; Kharitonchik LA; Kodentsova VM
    Vopr Pitan; 1999; 68(5-6):19-22. PubMed ID: 10641276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
    Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV
    Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of patients with ischemic heart diseases using senzit].
    Zamotaev IP; Venediktova MG; Zakharova GIu
    Klin Med (Mosk); 1988 Aug; 66(8):68-71. PubMed ID: 3193737
    [No Abstract]   [Full Text] [Related]  

  • 45. The identification and management of patients with a high risk for cardiac arrhythmias during modified ECT.
    Gerring JP; Shields HM
    J Clin Psychiatry; 1982 Apr; 43(4):140-3. PubMed ID: 7068545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Intravenous fibrinolytic treatment in chronic ischemic heart disease (author's transl)].
    Sievers D; Blümchen G; Schmidtke I; Barthel W; Brandt D; Scharf-Bornhofen E; Schoop W
    Z Kardiol; 1981 Jan; 70(1):32-8. PubMed ID: 7210776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of biologically active supplements on the antioxidant and vitamin status of patients with hypertension and ischemic heart disease].
    Tutel'ian VA; Pogozheva AV; Rumiantseva OI; Akol'zina SE; Lysikova SL; Kodentsova VM; Mal'tsev GIu
    Vopr Pitan; 2001; 70(1):12-4. PubMed ID: 11338339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of an overall coronary bed affection in heart remodeling in patients with stenocardia and arterial hypertension].
    Dmitriev VL; Volkova EG; Levashov SIu
    Ter Arkh; 2002; 74(4):53-5. PubMed ID: 12043241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The role of contraction asynchronism of the heart ventricles in the pathogenesis of pulmonary hypertension in ischemic heart disease].
    Denisiuk VI
    Vrach Delo; 1988 Jul; (7):31-3. PubMed ID: 3188459
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
    Mehta S; Fawzi W
    Vitam Horm; 2007; 75():355-83. PubMed ID: 17368322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vitamins in neurology].
    Kanig K
    Bibl Psychiatr Neurol; 1969; 139():60-87. PubMed ID: 4257723
    [No Abstract]   [Full Text] [Related]  

  • 52. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
    Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
    Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pantothenic acid metabolic disorder and its relation to the change in energy processes in patients with ischemic heart disease and hypertension].
    Borets VM; Ovchinnikov VA; Mironchik VV; Moĭseenok AG; Lis MA
    Vopr Pitan; 1983; (1):45-9. PubMed ID: 6837001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Vitamin disturbances in chronic renal insufficiency. I. Water soluble vitamins].
    Pietrzak I
    Przegl Lek; 1995; 52(10):522-5. PubMed ID: 8834846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
    Khomenko VL; Vasiuk IuA; Romashkin AV; Sivkov SI; Mel'nikov AIu; Buskin VD
    Sov Med; 1990; (3):64-7. PubMed ID: 2195673
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of hypolipidemic agents on the content of sterol-fibrinogen complexes of the blood in patients with ischemic heart disease].
    Palamarchuk VI; Fedorishko SS
    Vrach Delo; 1989 Jan; (1):39-41. PubMed ID: 2718441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Erythrocyte acid resistance in the drug treatment of heart failure in patients with ischemic heart disease].
    Sakharchuk II; Starodub NF; Sisetskiĭ AP; Artiukh VP; Denisenko GT
    Vrach Delo; 1991 May; (5):33-5. PubMed ID: 1866910
    [No Abstract]   [Full Text] [Related]  

  • 58. [Levels of serotonin in the blood and 5-hydroxyindoleacetic acid in the urine of patients with ischemic heart disease].
    Buslenko NS; Kuznetsova BA
    Kardiologiia; 1972 Sep; 12(9):39-43. PubMed ID: 4644951
    [No Abstract]   [Full Text] [Related]  

  • 59. [Changes of certain indicators of catecholamine metabolism in ischemic heart disease under the effect of Vitamin E, thioctic acid and their combination].
    Pchelintsev VP; Filonenko PI
    Ter Arkh; 1976; 48(10):131-3. PubMed ID: 799363
    [No Abstract]   [Full Text] [Related]  

  • 60. Vitamin requirements in different clinical conditions.
    Dickerson JW
    Bibl Nutr Dieta; 1985; (35):44-52. PubMed ID: 3890829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.